The “Great Gatsby Era” was an exciting time of new prosperity, infinite creativity and dramatic social change. Long-standing social norms and traditions gave way to the “mass culture” and consumerism that modernized American society. “What will they think of next?” was a popular expression that defined the era.
On the 100-year anniversary of this revolutionary decade, the pharma industry should take note: breaking from tradition is the catalyst for real, long-lasting transformation. Innovative therapies require innovative thinking.
In just the past 10 years, we’ve seen both clinical and manufacturing outsourced to single partners who successfully reduced costs, minimized risk, and maintained product integrity. Commercialization, on the other hand, is lagging behind and continues to be outsourced to multiple vendors, often creating silos and conflicting priorities amongst service providers. Let’s not forget the impact these silos have on data integration and transparency.
Download the full article, published in PharmaVOICE, to learn why breaking from the traditional commercialization model is the catalyst for long-lasting transformation.
EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…